Normal Saline IV Administration

BIOLOGICAL2 trials

Sponsors

Intellia Therapeutics

Conditions

Hereditary Angioedema

Phase 1

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Active, not recruitingNCT05120830

Intellia TherapeuticsHereditary Angioedema

Start: 2021-12-10End: 2026-07-01Updated: 2026-03-24

Phase 3

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Active, not recruitingNCT06634420

Intellia TherapeuticsHereditary Angioedema

Start: 2025-01-15End: 2027-09-01Updated: 2026-07-29

Related Papers

CRISPR-Based Therapy for Hereditary Angioedema

New England Journal of Medicine2024-10-2434 citations

CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema

New England Journal of Medicine2024-01-31136 citations